Disorders of sodium and water metabolism are frequently encountered in hospitalized patients. Hyponatremia in critically ill patients can cause significant morbidity and mortality. Inappropriate treatment of hyponatremia can add to the problem. The diagnosis and management of salt and water abnormalities in critically ill patients is often challenging. The increasing knowledge about aquaporins and the role of vasopressin in water metabolism has enhanced our understanding of these disorders. The authors have outlined the general approach to the diagnosis and management of hyponatremia. A systematic approach by clinicians, using a detailed history, physical examination, and relevant diagnostic tests, will assist in efficient management of salt and water problems.
Get full access to this article
View all access options for this article.
References
1.
1. Baran D, Hutchuinson TA. Outcome of hyponatremia in general hospital population . Clin Nephrol. 1984;22: 72-76 .
2.
2. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin . Ann Intern Med. 1985;102: 164-168 .
3.
3. Baylis PH, Thompson CJ. Osmoregulation of vasopressin and secretion and thirst in health and disease . Clin Endocrinol. 1988;29: 549-576 .
4.
4. McKenna K, Thompson CJ. Osmoregulation in clinical disorders of thirst appreciation . Clin Endocrinol. 1998;49: 139-152 .
5.
5. Bankir L, Bouby N, Trinh-Trang-Tan MM. The role of the kidney in the maintenance of water balance . Clin Endocrinol Metab. 1989;3: 229-311 .
6.
6. Knepper MA, Rector FC Jr. Urinary concentration and dilution. In: Brenner BM, Rector FC Jr, eds. The Kidney. Philadelphia, Pa: Saunders ; 1995:532-570.
7.
7. Kokko JP, Rector FC Jr. Countercurrent multiplication system without active transport in inner medulla: new model . Kidney Int. 1972;2: 214-223 .
8.
8. Neilsen S, Agre P. The aquaporin family of water channels in kidney . Kidney Int. 1995;48: 1057-1068 .
9.
9. Nielsen S, Kwon TH, Christensen BM, Promeneur D, Frokiaer J, Marples D. Physiology and pathophysiology of renal aquaporins . J Am Soc Nephrol. 1999;10: 647-663 .
10.
10. Yamamoto T, Sasaki S. Aquaporins in the kidney: emerging new aspects . Kidney Int. 1998;54: 1041-1051 .
11.
11. Knepper MA, Wade JB, Terris J, Ecelbarger CA, Marples D, Mandon B, Chou CJ, Kishore BK, Nielsen S. Renal aquaporins . Kidney Int. 1996;49: 1712-1717 .
12.
12. Nonoguchi H, Sands JM, Knepper MA. Atrial natriuretic factor inhibits vasopressin stimulated osmotic water permeability in rat inner medullary collecting duct . J Clin Invest. 1988;82: 1383-1390 .
13.
13. Mandell IN, DeFronzo RA, Robertson GL, Forrest JN. Role of plasma vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat . Kidney Int. 1980;17: 186-195 .
14.
14. Elalouf JM, Sari DC, deRouffignac C. Effects of glucagons and the parathyroid hormone on the loop of Henle of rat juxtamedullary nephrons . Kidney Int. 1986;29: 807-813 .
15.
15. Carney S, Morgan T, Ray C, Thompson L. Effect of calcitonin on urine concentration in the rat . Am J Physiol. 1983;244: F432-F435 .
16.
16. Beck TR, Dunn MJ. The relationship of vasopressin and renal prostaglandins . Miner Electrolyte Metab. 1981;6: 46-59 .
17.
17. Landenson JH, Apple FS, Koch DD. Misleading hyponatremia due to hyperlipidemia: a method dependent error . Ann Int Med. 1981;95: 707-708 .
18.
18. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide induced hyponatremia: reproducibility by single dose rechallenge and an analysis of pathogenesis . Ann Intern Med. 1989;110: 24-30 .
19.
19. Fichmann MP, Vorrherr H, Kleeman CR, Telfer N. Diuretic induced hyponatremia . Ann Intern Med. 1971;75: 853-863 .
20.
20. Sonnenblick M, Friedlander Y, Rosin A. Diuretic induced hyponatremia . Chest. 1993;103: 601-606 .
21.
21. Boykin J, deTorrnte A, Robertson GL, Erickson A, Schrier RW. Persistent plasma vasopressin levels in hypoosmolar state associated with mineralocorticoid deficiency . Miner Electrolyte Metab. 1979;2: 310-315 .
22.
22. Peters JP, Welt KG, Sims EAH, Orloff J, Needham J. A salt wasting syndrome associated with cerebral disease . Trans Assoc Am Physiol. 1950;63: 57-64 .
23.
23. Harrigan MR. Cerebral salt wasting . Crit Care Clin. 2001;17: 125-138 .
24.
24. Weinand ME, O’Boynick PL, Goetz KL. A study of serum antidiuretic hormone and atrial natriuretic peptide levels in a series of patients with intracranial disease and hyponatremia . Neurosurgery. 1989;25: 781-785 .
25.
25. Damraju SC, Rajshekhar V, Chandy MJ. Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis . Neurosurgery. 1997;40: 312-317 .
26.
26. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin . Ann Int Med. 1985;102: 164-168 .
27.
27. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia . Am J Med. 1999;106: 399-403 .
28.
28. Silver SM, Kozlowki SA, Baer JE, Rogers SJ, Sterns RH. Glycine induced hyponatremia in the rat: a model of post-prostatectomy syndrome . Kidney Int. 1995;47: 262-268 .
29.
29. Istre O, Bjoennes J, Naess R, Hornbaek K, Forman A. Post operative cerebral edema after transcervical endometrial resection and uterine irrigation with 1.5% glycine . Lancet. 1994;344: 1187-1189 .
31. George JM, Capen CC, Phillips AS. Biosynthesis of vasopressin in vitro and ultrastructure of bronchogenic cancer . J Clin Invest. 1972;51: 141-148 .
32.
32. Robertson GL. Syndrome of inappropriate diuresis . N Engl J Med. 1989;321: 538-539 .
33.
33. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema . Am J Med. 1978;64: 613 .
34.
34. Iwasaki Y, Oiso Y, Yamanouchi K. Osmoregulation of plasma vasopressin in myxedema . J Clin Endocrinol Metab. 1990;70: 534-539 .
35.
35. Oelkers W. Hyponatremia and inappropriate secretion of antidiuretic hormone in patients with hypopituitarism . N Engl J Med. 1989;321: 492 .
36.
36. Green HH, Harrington AR, Valtin H. On the role of antidiuretic hormone in the inhibition of acute water diuresis in adrenal insufficiency and the effects of gluco- and miner-alocorticoids in revising the inhibition . J Clin Invest. 1970;49: 1724-1736 .
37.
37. Riggs AT, Dysken MW, Kim SW, Opsahl JA. Review of disorders of water homeostasis in psychiatric patients . Psychosomatics. 1991;32: 133-148 .
38.
38. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia . N Engl J Med. 1988;318: 397-403 .
39.
39. Schrier RW, Fassett RG. Pathogenesis of sodium and water retention in cardiac failure . Renal Failure. 1998;20: 773-781 .
40.
40. Schrier RW, Martin PY. Recent advances in the understanding of water metabolism in heart failure . Adv Exp Med Biol. 1998;449: 415-426 .
41.
41. Xu DL, Martin PY, Ohara M, St John J, Pattison T, Meng X, Morris K, Kim JK, Schrier RW. Upregulation of aquaporin water channel expression in chronic heart failure in rats . J Clin Invest. 1997;99: 1500 .
42.
42. Gross P, Reimann D, Henschkowski J. Treatment of severe hyponatremia: conventional and novel aspects . J Am Soc Nephrol. 2001;12: S10-S14 .
43.
43. Laureno R, Karp BI. Myelinosis after correction of hyponatremia . Ann Intern Med. 1997;126: 57 .
44.
44. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York, NY: McGraw-Hill ; 2001.
45.
45. Adrogue H, Madias N. Hyponatremia . N Engl J Med. 2000;342; 1581-1590 .
46.
46. Halperin ML, Oh MS. The Dysnatremias: Hyponatremia and Hypernatremia: Current Therapy in Nephrology and Hypertension. 4th ed. St Louis, Mo: Mosby ; 1998.
47.
47. Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia . Kidney Int. 1991;39: 1274 .
48.
48. Riegger GA, Kochsiek K. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to dilated cardiomyopathy . Am J Cardiol. 1986;58: 300 .
49.
49. Sterns RH. The treatment of hyponatremia: first, do no harm . Am J Med. 1990;88: 557 .
50.
50. Palm C, Gross P. V2-vasopressin receptor antagonists—mechanisms of effect and clinical implications in hyponatremia . Nephrol Dial Transplant. 1999;14: 2559 .
51.
51. Martinez-Castelao A. Lixivaptan (American Home Products) . Curr Opin Invest Drugs. 2001;2: 525-530 .
